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Introduction
Mesenchymal stem cells (MSC), or as proposed
recently multipotent stromal cells [1], reside in small
numbers in bone marrow (BM) and other tissues and
have been shown to be relatively easy to expand ex
vivo. MSC differentiate in vitro and in vivo into differ-
ent connective tissue cells types including osteoblasts,
adipocytes, chondrocytes, endothelial or myogenic
cells [2-4]. This multidifferentiation potential of MSC
raised a clinical interest to employ these cells for
regeneration purposes e.g., in Osteogenesis Imperfec-
ta, stroke or heart infarct. MSC lack also MHC-II anti-
gens and possess immunomodulatory properties which
enable them, for example to ameliorate GvHD after
hematopoietic transplantation [5-7]. 
Since their first description in the bone marrow by
Friedenstein and co-workers [8], MSC have been rou-
tinely isolated based on their adherence to plastic. A
disadvantage of this isolation strategy is the possibili-
ty of hematopoietic contamination and heterogeneity
of starting population of adherent fraction of bone
marrow mononuclear cells (BMMNC). This, in turn,
will involve a development of more effective strategies
to purify these cells directly from harvested BMMNC.
The exact phenotype of MSC is not known, but as sug-
gested in the recent publications they should be
enriched in SSEA+lin-CD45- fractions of BMMNC
[9]. Furthermore, the most primitive BM-residing cells
such as VSEL stem cells [10], MAPC [11] or MIAMI
cells [12] could be precursors of BM-derived non-
hematopoietic stem cells - including MSC.
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Abstract: Mesenchymal Stem Cells (MSC) are employed in gene and cellular therapies. Routinely MSC are isolated from
bone marrow mononuclear cells (MNC) by plastic adherence. Here we compared new isolation strategies of bone marrow
MSC including immunodepletion of hematopoietic cells and immunomagnetic isolation of CD105+ and CD271+ popula-
tions. Four fractions were obtained: MNC MSC, RosetteSep-isolated MSC, CD105+ and CD271+ sorted MSC. We evaluat-
ed i) number of CFU-F colonies, ii) cell phenotype, iii) in vitro differentiation of expanded cells and iv) expression of
osteo/adipogenesis related genes. Results: Average number of day 9 CFU-F colonies was the highest for CD271 positive
fraction. Real-Time PCR analysis revealed expression of RUNX2, PPARγ and N-cadherin in isolated cells, particularly high
in CD271+ cells. Expression of CD105, CD166, CD44, CD73 antigens was comparable for all expanded populations (over
90%). We observed various levels of hematopoietic contamination with the highest numbers of CD45+ cells in MNC-MSC
fraction and the lowest in CD105+ and CD271+ fractions. Cells of all the fractions were CD34 antigen negative. Expanded
CD105 and CD271 populations showed higher level of RUNX2, osteocalcin, PTHR, leptin, PPARγ2 and aggrecan1 genes
except for α1 collagen. After osteogenic differentiation CD105+ and CD271+ populations showed lower expression of
RUNX, PPARγ2 and also lower expression of osteocalcin and PTHR than MNC, with comparable α1-collagen expression.
Chondrogenic and adipogenic gene expression was higher in MNC.  More clonogenic CD105+ and particularly CD271+
cells, which seem to be the most homogenous fractions based on Real-Time PCR and immunostaining data, are better suit-
ed for MSC expansion. 
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In contrast, the phenotype of MSC expanded/dif-
ferentiated in in vitro cultures from BM-derived pre-
cursors is better described and these expanded ex vivo
cells were found to be Stro-1+, CD105+, CD73+,
CD29+, CD166+, CD106+, CD44+, HLA-ABC+,
CD90+ and at the same time CD45-, CD34-, CD14-,
HLA-DR- [2,13,14]. They also express receptors for
different growth factors such as PDGF-R, EGF-R,
IGF-R or NGF-R [15,16]. 
Based on these phenotypic analysis alternative iso-
lation protocols were proposed to include negative and
positive selection strategies or combination of both.
Negative isolation strategies are based on enrichment
of MSC by depletion of myeloid and lymphoid cells by
immunomagnetic sorting [17-19]. In contrast, positive
isolation strategies are based on the selection of the
cells that express e.g. Stro-1, CD105, CD271 or CD34
antigen by immunomagnetic beads [15,20-22] or fluo-
rescence-activated cell sorting (FACS) [23,24].
Recently, a strategy has been proposed to sort double
positive population of cells which express Stro-1 and
CD34 or SBA and CD34 [24]. Positive immunomag-
netic selection could be also combined during single
isolation strategy with FACS e.g. to isolate Stro-
1+CD106+ cells [25] or D7-FIB+ CD45+ and CD271+
cells [26]. Similarly, it has been proposed to deplete
immunomagnetically CD45 and CD14 cells before
FACS isolation of CD73, CD90 or CD105 positive
cells [27]. 
In this study we have evaluated four fractions: i)
non-purified BMMNC, ii) BM enriched for MSC by
RosetteSep Isolation Kit, and immunemagnetically
selected iii) CD105+ and iv) CD271+ cells for i) their
efficacy to form CFU-F colonies, ii) expression of
MSC-associated antigens (CD105, CD166, CD44,
CD73, CD45, CD34) and genes (e.g. RUNX2,
PPARγ2, osteocalcin, N-cadherin) and iii) their
adipocyto/osteogenic potential in vitro. 
Materials and methods
Bone marrow samples. Bone marrow samples were aspirated
from pelvic bones of healthy donors with their prior consent
obtained according to the procedures approved by the Ethics Com-
mittee of the Jagiellonian University. 
Isolation of BM-derived MSCs. Four isolation strategies (Fig. 1)
starting from the same amount of bone marrow sample were
applied to evaluate whether the way of isolation strategy influences
MSC expansion efficacy and differentiation potential of expanded
MSCs.
A population enriched in MSC were isolated by negative
immunoselection (RosetteSep Isolation Kit, StemCell Technolo-
gies Inc., Vancouver, Canada no. 15128) according to manufactur-
er's instructions. In brief, cells were incubated for 25 minutes with
the depletion cocktail of tetrameric antibodies at room tempera-
ture. Then the cells were diluted with PBS and isolated by density
gradient centrifugation. A desired population, located in the inter-
fase was collected and washed in PBS. To obtain LD-MNCs bone
marrow sample was layered on a Lymphocytes Separation Medi-
um (PAA Laboratories GmbH, Goetzis, Austria) [28]. For isolation
of CD105 population the LD-MNCs were incubated with magnet-
ic microbeads conjugated to human CD105 monoclonal antibody
(Miltenyi Biotec, Germany) for 15 minutes at 4°C, rinsed and
placed on a miniMACS column.  For isolation of CD271 popula-
tion the LD-MNCs were incubated with APC-conjugated ME20.4-
1.H4 mAb labeling the LNGF receptor (or p75 NTR) (Miltenyi
Biotec, Germany) for 10 minutes at 4°C, rinsed, incubated with
anty-APC immunomagnetic beads for 15 minutes at 4°C, and
placed on a miniMACS column. After isolation the cells were
counted and assessed for viability. Their purity was determined by
flow cytometry. 
Culture of BM MSCs. BM mononuclear cells or cells from other
fractions were plated into vented 25 cm2 tissue culture flask (Sarst-
edt, Newton USA) with Dulbecco's-Modified Eagles Medium
(DMEM, Sigma-Aldrich Germany D5523) supplemented with
10% FBS (Stem Cell Technologies, Vancouver Canada 06472) and
antibiotics (PAA Laboratories GmbH, Goetzis, Austria). Medium
plating density were as follows: MNC MSC - 17 × 106; Roset-
teSep-isolated MSC - 2.4 × 106; CD105+ - 0.29 x 106; CD271+ -
0.22 × 106 per 25 cm2 flask. Flasks were incubated at 37°C in a
humidified atmosphere containing 5% CO2 and after 7 days half
of the medium was replaced with a fresh one. Than the cells were
cultured with a half medium change every week until the fibrob-
last-like cells at the base of the flask reached confluence. On
reaching confluence, the adherent cells were detached using
0.25% trypsin and re-seeded at 1 x 105 cells per 25 cm2 flask -
4000 per 1 cm2 (first passage). These cells were incubated again
until confluence, and were once again trypsinized and re-seeded
at 1 × 105 cells per 25 cm2 flask - 4000 per 1 cm2 (second pas-
sage). At the end of second passage when the cells reached con-
fluence, they were trypsinized and either cryo-preserved or used
immediately [29].
Staining of CFU-F colonies. For an assessment of capability of
MSC to form CFU-F colonies cells were cultured 9 days [30]. On
day 9 the flasks were rinsed, fixed with methanol and stained with
Wright solution and the number of colonies was counted.
Flow cytometry. MSC phenotype was analyzed with the panel of
mouse mAb specific for MSC - CD73, CD105, CD166 and
hematopoietic cells - CD45 (Becton Dickinson). Briefly, to 1×105
cells suspended in 100 µl of staining buffer (PBS, 2% FBS) 20 μl
of mouse mAb was added. Next, the cells were incubated in the
dark for 30 min at 4°C. Stained cells were washed, collected using
FACSCanto cytometer (Becton Dickinson; USA) and analyzed
with FACS Diva software (Becton Dickinson; USA). 
Evaluation of in vitro differentiation potential of MSCs. 
Osteogenic differentiation. To induce osteogenic differentiation,
5×104 cultured cells were plated in 24-well plate (Sarstedt, Becton
Dickinson) in Nonhematopoietic OsteoDifferentiation Medium
(Miltenyi Biotec, Germany, order no.: 130-091-678). Cells were
cultured for 30 days with twice weekly refeeds. To demonstrate
osteogenic differentiation, the cultures were washed with phos-
phate-buffered saline, fixed with 4% paraphormaldehyde for 2
min., washed with distilled water, stained with alizaryn red S for 1
min. and finally washed with ethanol in order to assess calcium
phosphate deposits. 
Adipogenic differentiation. To induce adipogenic differentiation,
10×104 cultured cells were plated in 6-well plate (Sarstedt, Newton
USA) in Nonhematopoietic AdipoDifferentiation Medium (Mil-
tenyi Biotec, Germany, order no.: 130-091-677). Cells were cul-
tured for 30 days with twice weekly refeeds. The cells containing
lipid vacuoles were observed after 2 or 3 weeks.
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RNA Extraction and Reverse Transcription. Total RNA was
extracted using RNeasy Mini Kit (Quiagen) followed by DNAse
treatment (Promega). The reverse polymerase transcription was
performed using MMLV reverse transcriptase (Invitrogen) accord-
ing to manufacturer's protocol. 
Quantitative Real-Time PCR Analysis. Detection of mRNA lev-
els was performed by real-time PCR assay on ABI PRISM 7300
Sequence Detection System (Applied Biosystems, Foster City,
CA). Specific primers-probe set were purchased from Applied
Biosystems: N-cadherin Hs00169953_m1, RUNX2
Hs00231692_m1, PPARγ2 Hs01115513_m1, osteocalcin
Hs01587814_m1, PTHR Hs00896835_g1, α1-collagen
Hs01076780_m1, LEP Hs01084494_m1, LPL Hs01012569_m1,
aggrecan Hs01048727_m1). The mRNA expression level for all
samples was normalized to the housekeeping gene GAPDH.
Statistical analysis. Data for number of cells seeded, number of
CFU-F colonies, expression level of chosen antigens are repre-
sented by the mean and a range. Data for mRNAs expression level
are represented by the mean and standard deviation (SD). 
Results
Influence of isolation mode on CFU-F colonies
number
Bone marrow samples (n=3) were divided into two
parts (3/4 and 1/4) and processed as described below
(Fig. 1). Accordingly, the part containing 3/4 of mar-
row sample was enriched for BMMNC by Ficoll gra-
dient centrifugation and subsequently the cells har-
vested from interphase were divided into three equal
parts. One equal part of these cells was directly seeded
into the culture flask whereas the second and third part
were subjected to isolation of CD105+ and CD271+
cells, respectively. The remaining 1/4 of initially har-
vested BM samples were directly enriched for MSC by
employing RosetteSep Isolation Kit. 
Based on processing strategy four fractions of
BMMNC were obtained: 1) unpurified BMMNC, 2)
RossetteSep isolated BMMNC and purified 3)
CD105+ and 4) CD271+ cells. These cells were subse-
quently counted before plating to assess their seeding
density. The mean and range of seeding density was
for BMMNC 17 × 106 (10.3-28), for RosetteSep 2.4 ×
106 (1.1-4.2), for CD105+ 0.29 × 106 (0.08-0.75) and
for CD271+ cells 0.22 × 106 (0.11-0.38) (Table 1). On
average BMMNC seeding density was 7 times higher
than RosetteSep and 58 and 77 times higher than for
CD105+ and CD271+ populations, respectively. The
four groups of isolated cells were seeded into 25 cm2
flacks and cultured for 9 days.
We noticed that the CD105+ and CD271+ cells isolat-
ed by immunomagnetic beads yielded the highest num-
ber of CFU-F colonies (Table 1). Accordingly, the num-
ber of CFU-F colonies was 3-4 times higher as compared
to unpurified BMMNC. Interestingly, CFU-F formed by
purified CD271 and CD105 proliferated most rapidly
and the cultures initiated by these cells became confluent
faster in comparison to unpurified BMMNC or Roset-
teSep-isolated MSC (data not shown). 
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Table 1. Influence of MSC isolation method on CFU - F number. Bone marrow samples were divided into four portions. Each portion
was subjected to MSC isolation with a different isolation strategy and cells were plated to grow CFU-F. Purified fractions were seeded in
much lower initial density compared to BMMNC fraction. After 9 days the number of CFU-F colonies was scored under light microscope.
Data are presented as a mean value and a range (n=3).
Fig. 1. Scheme of MSC isolation. Whole bone marrow aspirates
were divided into two parts (3/4 and 1/4). Smaller part was incu-
bated with RossettSep depletion (StemCell Technologies Inc.
Canada) and subsequently MSC were isolated by density centrifu-
gation. From larger part BMMNC were isolated by density cen-
trifugation. Next, mononuclear cells were divided into 3 parts. One
part was directly seeded into culture flasks and from other two
parts CD105 and CD271 positive cells were isolated using
immunomagnetic beads (Miltenyi Biotec, Germany)
Quantification of osteogenic, adipogenic 
and chondrogenic gene expression in freshly
isolated cell fractions
We employed real time RT-PCR to study expression of
early (RUNX2, PPARγ2) and late (osteocalcin, PTHP,
α1collagen, aggrecan1, LEP) osteogenic, adipogenic
and chondrogenic genes in freshly isolated cell frac-
tions. Figure 2 panel A shows that the expression of
RUNX2 was the highest in purified CD271+ cells. The
CD271+ and RosetteSep+ cells displayed also the high-
est expression of N-cadherin. Furthermore, CD271,
RosetteSep and CD105 cells expressed mRNA for
PPARγ at higher level than BMMNC. BMMNC
expressed also the lowest level of late osteogenic
genes (Fig. 2 panel B). Worthy of note is the fact that
we did not detect expression of aggrecan1 and LEP in
freshly isolated cell fractions (the data not shown). 
Phenotypic analysis of CFU-F-derived cells
All four cell fractions were plated to grow CFU-F and
subsequently CFU-F derived MSC were expanded
during three passages. For analysis of MSC-related
cell surface markers expression the cells were harvest-
ed and stained with antibodies against CD73, CD105,
and CD166. CFU-F derived cells were also stained for
expression of hematopoietic antigen CD45. Table 2
shows that expression pattern of evaluated MSC mark-
ers between cells from all four fractions was similar.
Some of CFU-F derived cells expanded from
BMMNC, RosetteSep and CD105+ selected cells
expressed CD45 antigen, and the cells isolated with
anti CD271 antibodies were highly depleted from con-
taminating CD45+ hematopoietic cells (Table 2).
Osteogenic and adipogenic differentiation
potential of MSC
CFU-F cells expanded for three passages were subse-
quently plated in the cultures promoting osteogenic
and adipogenic differentiation and after 30 days
stained with Alizarin S and Oil Red to visualize calci-
um-phosphate deposits and presence of lipid droplets,
respectively. As shown in Figure 3 no differences in
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Table 2. Characterisation of MSC obtained by different isolation strategies. Cells were cultured for three passages and antigen expression
was determined by FACS analysis. Data are presented as a mean value and a range (n=3).
Fig. 2. RQ-PCR analysis of mRNA expression for osteo, adipo and
chondrogenic genes on freshly isolated cells. A. early osteo and
adipogenesis related genes. B. late osteo and adipogenesis related
genes. A representative result is shown out of two independent
experiments.
differentiating potential were observed among MSC
cells obtained through different isolation procedures. 
Osteogenic and adipogenic mRNA expression
pattern in expanded and differentiated toward
osteogenesis MSC
The analysis of gene expression profile performed on
expanded for three passages MSC revealed differences
in expression of early osteogenic (RUNX2) and adi-
pogenic (PPARγ2) genes. Accordingly, MSC expanded
from CD105+ and CD271+ cells displayed a higher
expression of RUNX2 and PPARγ2 as compared to
MSC derived from BMMNC and RossetteSep cells
(Fig. 4 panel A). Osteocalcin, PTHR and α1collagen
were expressed at higher level in MSC-expanded from
RossetteSep-, CD105+- and CD271+-derived cells as
compared to BMMNC-derived MSC (Fig. 4 panel B).
Similarly, these fractions exhibited higher expression
of  aggrecan1 and LEP (Fig. 4 panel C). 
After osteogenic differentiation of MSC we
observed only small differences in gene expression
profiles (Fig. 5). 
Accordingly, the levels of mRNA for early
osteogenic RUNX2 and early adipogenic PPARγ2 (Fig.
5 panel A) as well as late osteogenic osteocalcin and
PTHR (Fig. 5 panel B) and late chondrogenic aggre-
can1 (Fig. 5 panel C) genes were comparable with dif-
ferences oscillating around two folds between the frac-
tions. 
The only higher difference was observed for
CD271+- and RosetteSep-derived MSC which present-
ed lower expression of mRNA for LEP as compared to
MSC expanded from BMMNC and CD105+ cells (Fig.
5 panel C).
Discussion
Since their initial discovery, MSC isolation procedure
is still based on their plastic adherence properties
[8,29,31,32]. In this study we compared side by side
expansion and differentiation efficacy of MSC isolated
by employing three different commercially available
isolation strategies to adherence based protocol. Our
data reveal that MSC purification using various isola-
tion strategies results in different proliferation capaci-
ty of these cells and different patterns of gene expres-
sion. 
Positive selection strategies based on use of CD105
and CD271 antibodies yielded four and five times
more CFU-F colonies respectively in comparison to
BMMNC and population enriched for MSC by nega-
tive selection. Consequently, cultures started from
CD105+ and CD271+ cells reached confluence and
proliferated faster than those initiated from BMMNC
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Fig. 3. Assessment of in vitro differentiation potential. Expanded
cells after the third passage were differentiated for  30 and 20 days,
into osteo- or adipocytic lineage respectively. Calcium phosphate
deposits and presence of lipid droplets were evaluated microscop-
ically (magnification ×400).
Fig 4. RQ-PCR analysis of mRNA expression for osteo, adipo and
chondrogenic genes after three passages. Panel A - early osteo and
adipogenesis related genes. Panel B - late osteo and adipogenesis
related genes. A representative result is shown out of two inde-
pendent experiments. 
or cells enriched by RosetteSep Isolation Kit. The pos-
sible explanation for this kind of difference is the fact
that when cultured without accompanying hematopoi-
etic cells present in MNC and RosetteSep fractions,
proliferation potential of CD105 [20,27,33] and
CD271 cells [22,26] is unlashed. This suggests that the
growth of these cells is inhibited by hematopoietic
cells present in MNC and RosetteSep fractions. It is
also possible that lower seeding density is advanta-
geous in MSC expansion. Such phenomenon was
already described [35,36]. Positively isolated fractions
were seeded at much lower density than MNC, which
may be the reason for observed higher number of
CFU-F colonies. Furthermore, in MSC cultures started
from BMMNC we sometimes observed appearance of
round, strongly proliferated cells attached to adherent
cells, which transferred with MSC to the next passage.
Such cultures usually stopped proliferating. At the
same time such phenomenon was not observed in cul-
tures started from other fractions isolated from the
same bone marrow sample
Most of the data on MSC are obtained after pro-
longed culture in vitro. Thus, we also cultured purified
cells for three passages to perform further evaluation
of each fraction. Phenotype evaluation revealed that
CD271+ population contained the lowest hematopoiet-
ic contamination as judged by presence of CD45 posi-
tive cells. Also CD105 fraction has on average lower
number of CD45+ cells in comparison to MNC and
RosetteSep populations. Lack of hematopoietic con-
tamination persisting until the third passage might be
at least in part responsible for observed faster CD271+
and CD105+ populations' proliferation.
In addition to the highest number of CFU-F
colonies observed in CD271+ fraction, these cells, in
comparison to other populations, had higher expres-
sion level of RUNX2 and PPARγ2, transcription fac-
tors pivotal in the early differentiation of bone, and
adipose tissues [37-39]. 
Freshly isolated CD271 cells and RosetteSep cells
also highly expressed mRNA for N-cadherin. At the
same time CD105 cells seem to be depleted of N-cad-
herin expressing cells when compared to MNC. Pres-
ence of N-cadherin positive cells in CD271 and Ros-
setteSep fractions is intriguing in the light of recent
reports showing that spindle-shaped, N-cadherin+
osteoblasts (SNO) form niches supporting hematopoi-
etic cells development [40]. Preservation or even
enrichment of SNO precursor cells before subsequent
transplantation could be of great importance for recon-
stitution of hematopoietic niches after myeloablative
therapies which negatively affect bone marrow
microenvironment [41-43]. 
Evaluation of gene expression profile of MSC
after third passage, but before differentiation,
revealed that differences in expression of early and
late osteogenic, adipogenic and chondrogenic genes
are still present; however, they are much lower than
those observed for freshly isolated cells. Cultures
started from CD271+ and CD105+ populations have
higher enrichment in molecular markers of early
osteo and adipo progenitors. Similarly, these popula-
tions have higher enrichment in late molecular mark-
ers for osteogenic progenitors (based on osteocalcin
and PTHR level). Molecular markers of late adipo
(LEP) and chondrogenic (aggrecan1) progenitors are
expressed at higher level in enriched fractions when
compared to MNC. In the light of these observations
we conclude that differences between initial popula-
tions, although still seen after third passage, decrease
during culture.
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Fig 5. RQ-PCR analysis of mRNA expression for osteo, adipo and
chondrogenic genes after osteodifferentiation process. Panel A -
early osteo and adipogenesis related genes. Panel B - late osteo and
adipogenesis related genes. A representative result is shown out of
two independent experiments. 
Osteogenic and adipogenic differentiation potential
of MSC expanded from MNC, RossetteSep, CD105 or
CD271 populations was already demonstrated [18,20-
22,26] but no parallel comparison of these cell frac-
tions was reported. In this study we show that osteo
and adipogenic differentiation potential of expanded
cells, as assessed by microscopic evaluation of calci-
um-phosphate deposits and lipid droplets appearance,
did not differ between fractions.
Evaluation of gene profile analysis after osteogenic
differentiation process confirmed microscopic obser-
vation. Level of molecular markers for early and late
osteo, adipo and chondrogenic progenitors showed
only small differences, which probably did not influ-
enced osteodifferentiation process. The only differ-
ences in higher expression (5 folds and 3 folds) were
observed for LEP mRNA expression for CD271+ and
RosetteSep populations when compared to MNC and
CD105+ cells. 
Our data indicate that isolation strategy based on
CD271 expression results in obtaining a cell popula-
tion which is highly enriched for molecular markers of
early osteo and adipo progenitors. Furthermore, this
strategy of bone marrow MSC purification led to the
highest number of CFU-F colonies after 9 days of cul-
ture. Cultures started from cells isolated based on
CD271 expression after three passages contained con-
siderably lowest hematopoietic contamination in com-
parison to cultures started from MSC isolated by other
strategies. Populations of these cells after three pas-
sages retained the highest level of molecular markers
for early osteo and adipo progenitors and together with
cells of other alternatively isolated populations
expressed higher level of molecular markers for late
osteo, adipo and chondrogenic progenitors. 
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